Variables | EFS | OS | ||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Univariate analyses | ||||
 MiR-425 (high vs. low) | 1.037 (0.624–1.724) | 0.888 | 1.073 (0.626–1.840) | 0.798 |
 WBC (≥ 20 vs. < 20 × 109/L) | 1.530 (0.910–2.571) | 0.108 | 0.949 (0.554–1.628) | 0.851 |
 FLT3-ITD (positive vs. negative) | 1.873 (1.020–3.437) | 0.043 | 1.998 (1.053–3.788) | 0.034 |
 NPM1 (mutated vs. wild) | 0.913 (0.515–1.619) | 0.755 | 0.879 (0.478–1.671) | 0.678 |
 DNMT3A (mutated vs. wild) | 1.106 (0.615–1.989) | 0.737 | 1.269 (0.686–2.347) | 0.447 |
 RUNX1 (mutated vs. wild) | 1.375 (0.650–2.907) | 0.404 | 2.253 (1.046–4.849) | 0.038 |
 TP53 (mutated vs. wild) | 1.579 (0.565–4.411) | 0.383 | 3.788 (1.289–11.133) | 0.015 |
 CEBPA (mutated vs. wild) | 0.853 (0.366–1.989) | 0.713 | 0.644 (0.256–1.620) | 0.350 |
 IDHI/IDH2 (mutated vs. wild) | 0.761 (0.417–1.389) | 0.374 | 0.802 (0.422–1.524) | 0.500 |
 NRAS/KRA S (mutated vs. wild) | 1.373 (0.622–3.034) | 0.433 | 0.658 (0.261–1.657) | 0.374 |
 MLL-PTD (mutated vs. wild) | 6.093 (2.051–18.098) | 0.001 | 3.106 (1.104–8.741) | 0.032 |
Multivariate analyses | ||||
 WBC (≥ 20 vs. < 20 × 109/L) | 1.691 (0.973–2.940) | 0.062 | – | – |
 FLT3-ITD (positive vs. negative) | 1.740 (0.934–3.239) | 0.081 | 2.549 (1.306–4.975) | 0.006 |
 TP53 (mutated vs. wild) | 2.657 (0.877–8.048) | 0.084 | 5.841 (1.895–18.009) | 0.002 |
 RUNX1 (mutated vs. wild) | – | – | 3.007 (1.355–6.673) | 0.007 |
 MLL-PTD (mutated vs. wild) | 6.028 (2.001–18.158) | 0.001 | – | – |